AT338795B - Verfahren zur herstellung von neuen 4'-alkyldioxyalkylen-5-benzylpyrimidinen und ihren saureadditionssalzen - Google Patents

Verfahren zur herstellung von neuen 4'-alkyldioxyalkylen-5-benzylpyrimidinen und ihren saureadditionssalzen

Info

Publication number
AT338795B
AT338795B AT215474A AT215474A AT338795B AT 338795 B AT338795 B AT 338795B AT 215474 A AT215474 A AT 215474A AT 215474 A AT215474 A AT 215474A AT 338795 B AT338795 B AT 338795B
Authority
AT
Austria
Prior art keywords
benzylpyrimidines
dioxyalkylene
alkyl
preparation
acid
Prior art date
Application number
AT215474A
Other languages
English (en)
Other versions
ATA215474A (de
Original Assignee
Heumann Ludwig & Co Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19732313361 external-priority patent/DE2313361C3/de
Application filed by Heumann Ludwig & Co Gmbh filed Critical Heumann Ludwig & Co Gmbh
Publication of ATA215474A publication Critical patent/ATA215474A/de
Application granted granted Critical
Publication of AT338795B publication Critical patent/AT338795B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT215474A 1973-03-17 1974-03-15 Verfahren zur herstellung von neuen 4'-alkyldioxyalkylen-5-benzylpyrimidinen und ihren saureadditionssalzen AT338795B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732313361 DE2313361C3 (de) 1973-03-17 2,4-Diamino-5-(3',5'-dimethoxy-4'-methoxyalkoxybenzyl-pyrimidine

Publications (2)

Publication Number Publication Date
ATA215474A ATA215474A (de) 1977-01-15
AT338795B true AT338795B (de) 1977-09-12

Family

ID=5875077

Family Applications (1)

Application Number Title Priority Date Filing Date
AT215474A AT338795B (de) 1973-03-17 1974-03-15 Verfahren zur herstellung von neuen 4'-alkyldioxyalkylen-5-benzylpyrimidinen und ihren saureadditionssalzen

Country Status (16)

Country Link
US (1) US3992379A (de)
JP (1) JPS584025B2 (de)
AR (1) AR207561A1 (de)
AT (1) AT338795B (de)
AU (1) AU476979B2 (de)
BE (1) BE812375A (de)
BR (1) BR7401966D0 (de)
CA (1) CA1063607A (de)
CH (1) CH601257A5 (de)
ES (1) ES424274A1 (de)
FR (1) FR2221147B1 (de)
GB (1) GB1413454A (de)
HK (1) HK50580A (de)
HU (1) HU166864B (de)
IT (1) IT1060117B (de)
NL (1) NL175414C (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115650A (en) * 1976-11-17 1978-09-19 Hoffmann-La Roche Inc. Process for preparing 2,4-diamino-5-(substituted benzyl)-pyrimidines
US4103902A (en) * 1977-08-16 1978-08-01 Foster Wheeler Energy Corporation Water seal for regenerator
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
DE3174994D1 (de) * 1980-11-27 1986-08-28 Wellcome Found Antibacterial benzylpyrimidines
JPS60107889U (ja) * 1983-12-20 1985-07-22 トキコ株式会社 給油量表示装置
DE3613794A1 (de) * 1986-04-24 1987-10-29 Frank Joachim Mueller Verfahren zum nachweis von antibiotika- und sulfonamidrueckstaenden in biologischen fluessigkeiten oder nahrungsmitteln

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909522A (en) * 1957-02-21 1959-10-20 Burroughs Wellcome Co Trialkoxybenzylpyrimidines and method
GB1142654A (en) * 1965-10-28 1969-02-12 Wellcome Found Cyano-acetals and their use in benzylpyrimidine synthesis
GB1229413A (de) * 1967-06-14 1971-04-21
US3849407A (en) * 1969-03-06 1974-11-19 Burroughs Wellcome Co 5-benzyl pyrimidines intermediates
US3819629A (en) * 1970-02-10 1974-06-25 Burroughs Wellcome Co Method for preparing 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
US3692787A (en) * 1970-02-16 1972-09-19 Burroughs Wellcome Co Substituted 2,4-diamino-5-benzyl pyrimidines
US3772289A (en) * 1970-10-22 1973-11-13 Burroughs Wellcome Co Alkyl substituted benzyl pyrimidines

Also Published As

Publication number Publication date
HK50580A (en) 1980-09-12
DE2313361A1 (de) 1975-02-06
FR2221147B1 (de) 1982-06-11
BR7401966D0 (pt) 1974-11-05
US3992379A (en) 1976-11-16
ATA215474A (de) 1977-01-15
JPS584025B2 (ja) 1983-01-24
CH601257A5 (de) 1978-06-30
IT1060117B (it) 1982-07-10
HU166864B (de) 1975-06-28
NL175414B (nl) 1984-06-01
ES424274A1 (es) 1976-11-01
AU6671374A (en) 1975-09-18
NL175414C (nl) 1984-11-01
FR2221147A1 (de) 1974-10-11
NL7403411A (de) 1974-09-19
CA1063607A (en) 1979-10-02
GB1413454A (en) 1975-11-12
BE812375A (fr) 1974-07-01
DE2313361B2 (de) 1975-07-10
JPS5035176A (de) 1975-04-03
AR207561A1 (es) 1976-10-15
AU476979B2 (en) 1976-10-07

Similar Documents

Publication Publication Date Title
AT336029B (de) Verfahren zur herstellung von neuen imidazotriazinen und ihren salzen
AT336604B (de) Verfahren zur herstellung von neuen triazolopyridazinen und ihren salzen
AT337190B (de) Verfahren zur herstellung von neuen fluoralkoxyphenyl-substituierten stickstoffheterozyklen und ihren salzen
AT321277B (de) Verfahren zur Herstellung von neuen 1,3-Diphenyl-propan-1-onen und ihren Salzen
AT315170B (de) Verfahren zur Herstellung von neuen 4[ω-(Flavon-7-yl-oxy)-alkyl]-piperazin-Derivaten und ihren Salzen
AT315831B (de) Verfahren zur Herstellung von neuen 4-Aza-benzimidazolderivaten und ihren Salzen
AT320655B (de) Verfahren zur Herstellung von neuen Piperazinderivaten und ihren Salzen
AT334370B (de) Verfahren zur herstellung von neuen triazoloisoindolderivaten und ihren salzen
AT331801B (de) Verfahren zur herstellung von neuen n-benzhydryl-n'-p-hydroxybenzyl-piperazinen und ihren saureadditionssalzen
ATA96474A (de) Verfahren zur herstellung von neuen thienotriazolodiazepin-derivaten und ihren salzen
AT337191B (de) Verfahren zur herstellung von neuen 3,4-dihydro-2h-naphthalinon-(1)-5-oxy-propyl-piperazin-derivate und ihren salzen
AT315862B (de) Verfahren zur Herstellung von neuen Diazepinderivaten und ihren Additionssalzen
ATA215474A (de) Verfahren zur herstellung von neuen 4'-alkyldioxyalkylen-5-benzylpyrimidinen und ihren saureadditionssalzen
AT338274B (de) Verfahren zur herstellung von neuen n-substituierten 1-amino-3-phenoxy-propanolen-(2) und ihren salzen
AT332425B (de) Verfahren zur herstellung von neuen 6-aminouracilen und ihren salzen
AT349018B (de) Verfahren zur herstellung von neuen 1,3-thiazoloisochinolin-derivaten und ihren salzen
ATA404376A (de) Verfahren zur herstellung von neuen 4,4-diphenyl-2-hydroxybutylaminen und ihren salzen
AT340430B (de) Verfahren zur herstellung von neuen benzodiazepinderivaten und ihren saureadditionssalzen
AT336620B (de) Verfahren zur herstellung von neuen piperazinderivaten und ihren salzen
AT332874B (de) Verfahren zur herstellung von neuen naphthyridinderivaten und ihren salzen
AT312600B (de) Verfahren zur Herstellung von neuen 5-Nitrothiazolderivaten und ihren Salzen
AT336623B (de) Verfahren zur herstellung von neuen triazolobenzodiazepinderivaten und ihren salzen
AT342044B (de) Verfahren zur herstellung von neuen 2-carbalkoxy- oder 2-carbaroxy-amino-benzimidazol-5 (6)-phenylathern und ihren salzen
AT308760B (de) Verfahren zur Herstellung von neuen Pyridazon-6-iminen und ihren Salzen
ATA882276A (de) Verfahren zur herstellung von neuen thienotriazolodiazepin-derivaten und ihren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties